{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T20:30:54Z","timestamp":1779309054735,"version":"3.51.4"},"reference-count":57,"publisher":"Tech Science Press","issue":"4","license":[{"start":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T00:00:00Z","timestamp":1710806400000},"content-version":"vor","delay-in-days":78,"URL":"https:\/\/doi.org\/10.32604\/TSP-CROSSMARKPOLICY"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OR"],"published-print":{"date-parts":[[2024]]},"DOI":"10.32604\/or.2023.043647","type":"journal-article","created":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T08:19:04Z","timestamp":1705306744000},"page":"753-768","update-policy":"https:\/\/doi.org\/10.32604\/tsp-crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Development of a cell adhesion-based prognostic model for multiple myeloma: Insights into chemotherapy response and potential reversal of adhesion effects"],"prefix":"10.32604","volume":"32","author":[{"given":"QIAN","family":"HU","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MENGYAO","family":"WANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JINJIN","family":"WANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YALI","family":"TAO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TING","family":"NIU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"17807","published-online":{"date-parts":[[2024]]},"reference":[{"key":"ref1","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1186\/s12885-019-6446-y","article-title":"Elucidating the expression and function of Numbl during cell adhesion-mediated drug resistance (CAM-DR) in multiple myeloma (MM)","volume":"19","author":"Huang","year":"2019","journal-title":"BMC Cancer"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s41232-020-00113-y","article-title":"Integrins in multiple myeloma","volume":"40","author":"Hosen","year":"2020","journal-title":"Inflammation and Regeneration"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"IJH39","DOI":"10.2217\/ijh-2021-0017","article-title":"Adhesion molecules in multiple myeloma oncogenesis and targeted therapy","volume":"11","author":"Bou Zerdan","year":"2022","journal-title":"International Journal of Hematologic Oncology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"100253","DOI":"10.1016\/j.jbo.2019.100253","article-title":"The role of CXCR4 in multiple myeloma: Cells\u2019 journey from bone marrow to beyond","volume":"17","author":"Ullah","year":"2019","journal-title":"Journal of Bone Oncology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"4462","DOI":"10.3390\/ijms22094462","article-title":"The role of marrow microenvironment in the growth and development of malignant plasma cells in multiple myeloma","volume":"22","author":"Giannakoulas","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/bjh.13596","article-title":"Therapeutic targeting of N-cadherin is an effective treatment for multiple myeloma","volume":"171","author":"Mrozik","year":"2015","journal-title":"British Journal of Haematology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1182\/blood-2006-07-035857","article-title":"Mechanisms of regulation of CXCR4\/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma","volume":"109","author":"Alsayed","year":"2007","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13045-016-0283-0","article-title":"Daratumumab: A first-in-class CD38 monoclonal antibody for the treatment of multiple myeloma","volume":"9","author":"Sanchez","year":"2016","journal-title":"Journal of Hematology & Oncology"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40779-021-00302-x","article-title":"Immunotherapeutic strategies targeting B cell maturation antigen in multiple myeloma","volume":"8","author":"Fang","year":"2021","journal-title":"Military Medical Research"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v039.i05","article-title":"Regularization paths for Cox\u2019s proportional hazards model via coordinate descent","volume":"39","author":"Simon","year":"2011","journal-title":"Journal of Statistical Software"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"810327","DOI":"10.3389\/fcell.2022.810327","article-title":"Blockade of GCH1\/BH4 axis activates ferritinophagy to mitigate the resistance of colorectal cancer to Erastin-Induced Ferroptosis","volume":"10","author":"Hu","year":"2022","journal-title":"Frontiers in Cell and Developmental Biology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ijbiomac.2016.05.050","article-title":"RBQ3 participates in multiple myeloma cell proliferation, adhesion and chemoresistance","volume":"91","author":"Liu","year":"2016","journal-title":"International Journal of Biological Macromolecules"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1096\/fj.07-081463","article-title":"Tastin is required for bipolar spindle assembly and centrosome integrity during mitosis","volume":"22","author":"Yang","year":"2008","journal-title":"FASEB Journal"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"8013","DOI":"10.18632\/aging.204332","article-title":"Noncoding RNAs-mediated overexpression of KIF14 is associated with tumor immune infiltration and unfavorable prognosis in lung adenocarcinoma","volume":"14","author":"Wang","year":"2022","journal-title":"Aging"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41419-021-03422-3","article-title":"TROAP switches DYRK1 activity to drive hepatocellular carcinoma progression","volume":"12","author":"Li","year":"2021","journal-title":"Cell Death & Disease"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"145575","DOI":"10.1016\/j.gene.2021.145575","article-title":"The function and pathogenic mechanism of filamin A","volume":"784","author":"Zhou","year":"2021","journal-title":"Gene"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1182\/blood-2013-12-544726","article-title":"Interaction of TIF-90 and filamin A in the regulation of rRNA synthesis in leukemic cells","volume":"124","author":"Nguyen","year":"2014","journal-title":"Blood"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"215647","DOI":"10.1016\/j.canlet.2022.215647","article-title":"Polyphyllin VII, a novel moesin inhibitor, suppresses cell growth and overcomes bortezomib resistance in multiple myeloma","volume":"537","author":"Wang","year":"2022","journal-title":"Cancer Letters"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/s11684-021-0836-7","volume":"15","author":"Li","year":"2021","journal-title":"Frontiers of Medicine"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.3390\/biom11101398","article-title":"Immunosuppressive roles of Galectin-1 in the tumor microenvironment","volume":"11","author":"Huang","year":"2021","journal-title":"Biomolecules"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1080\/10428190500126091","article-title":"Mechanisms of PECAM-1-mediated cytoprotection and implications for cancer cell survival","volume":"46","author":"Bergom","year":"2005","journal-title":"Leukemia & Lymphoma"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jprot.2014.01.022","article-title":"A comprehensive surface proteome analysis of myeloid leukemia cell lines for therapeutic antibody development","volume":"99","author":"Strassberger","year":"2014","journal-title":"Journal of Proteomics"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s13046-019-1147-6","article-title":"Anti-CD166\/4-1BB chimeric antigen receptor T cell therapy for the treatment of osteosarcoma","volume":"38","author":"Wang","year":"2019","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.14336\/AD.2022.0421","article-title":"Connexin43 in musculoskeletal system: New targets for development and disease progression","volume":"13","author":"An","year":"2022","journal-title":"Aging and Disease"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00018-019-03285-0","article-title":"Regulation of gap junction intercellular communication by connexin ubiquitination: Physiological and pathophysiological implications","volume":"77","author":"Totland","year":"2020","journal-title":"Cellular and Molecular Life Sciences"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.tcb.2009.11.001","article-title":"The gap junction proteome and its relationship to disease","volume":"20","author":"Laird","year":"2010","journal-title":"Trends in Cell Biology"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12964-022-01009-9","article-title":"The roles of connexins and gap junctions in the progression of cancer","volume":"21","author":"Zhou","year":"2023","journal-title":"Cell Communication and Signaling"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s40779-022-00432-w","article-title":"Expression dynamics of periodic transcripts during cancer cell cycle progression and their correlation with anticancer drug sensitivity","volume":"9","author":"Li","year":"2022","journal-title":"Military Medical Research"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.semcancer.2019.07.022","article-title":"Insights into new mechanisms and models of cancer stem cell multidrug resistance","volume":"60","author":"Garcia-Mayea","year":"2020","journal-title":"Seminars in Cancer Biology"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40779-022-00378-z","article-title":"N6-methyladenosine modification of CENPK mRNA by ZC3H13 promotes cervical cancer stemness and chemoresistance","volume":"9","author":"Lin","year":"2022","journal-title":"Military Medical Research"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3390\/cancers13010133","article-title":"The p53 pathway and metabolism: The tree that hides the forest","volume":"13","author":"Lahalle","year":"2021","journal-title":"Cancers"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/s41591-023-02321-8","article-title":"Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: The phase 2 ROAR trial","volume":"29","author":"Subbiah","year":"2023","journal-title":"Nature Medicine"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.1200\/JCO.20.00762","article-title":"Dabrafenib and Trametinib in patients with tumors with BRAFV600E Mutations: Results of the NCI-MATCH trial subprotocol H","volume":"38","author":"Salama","year":"2020","journal-title":"Journal of Clinical Oncology"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1158\/1078-0432.CCR-15-1076","article-title":"A phase II trial of AZD6244 (Selumetinib, ARRY-142886), an oral MEK1\/2 inhibitor, in relapsed\/refractory multiple myeloma","volume":"22","author":"Holkova","year":"2016","journal-title":"Clinical Cancer Research"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3390\/cancers9100133","article-title":"Platelet integrins in tumor metastasis: Do they represent a therapeutic target?","volume":"9","author":"Lavergne","year":"2017","journal-title":"Cancers"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13045-019-0709-6","article-title":"Platelet integrin \u03b1IIb\u03b23: Signal transduction, regulation, and its therapeutic targeting","volume":"12","author":"Huang","year":"2019","journal-title":"Journal of Hematology & Oncology"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.cbi.2016.04.014","article-title":"Cholinergic system and cell proliferation","volume":"259","author":"Campoy","year":"2016","journal-title":"Chemico-Biological Interactions"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"100741","DOI":"10.1016\/j.blre.2020.100741","article-title":"Autonomic nervous system control of multiple myeloma","volume":"46","author":"Cheng","year":"2021","journal-title":"Blood Reviews"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrd1612","article-title":"Erlotinib hydrochloride","volume":"4","author":"Minna","year":"2005","journal-title":"Nature Reviews Drug Discovery"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/ajh.26642","article-title":"Chronic myeloid leukemia: 2022 update on diagnosis, therapy, and monitoring","volume":"97","author":"Jabbour","year":"2022","journal-title":"American Journal of Hematology"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1200\/JCO.2017.74.7162","article-title":"Bosutinib versus imatinib for newly diagnosed chronic myeloid leukemia: Results from the randomized bfore trial","volume":"36","author":"Cortes","year":"2018","journal-title":"Journal of Clinical Oncology"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1182\/blood-2007-07-100362","article-title":"Erlotinib exhibits antineoplastic off-target effects in AML and MDS: A preclinical study","volume":"111","author":"Boehrer","year":"2008","journal-title":"Blood"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/s41388-023-02661-2","article-title":"KIF14 promotes proliferation, lymphatic metastasis and chemoresistance through G3BP1\/YBX1 mediated NF-\u03baB pathway in cholangiocarcinoma","volume":"42","author":"Jiang","year":"2023","journal-title":"Oncogene"},{"key":"ref45","first-page":"22975","article-title":"Silencing KIF14 reverses acquired resistance to sorafenib in hepatocellular carcinoma","volume":"12","author":"Zhu","year":"2020","journal-title":"Aging"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1128\/MCB.26.10.3853-3863.2006","article-title":"RNA interference-mediated silencing of mitotic kinesin KIF14 disrupts cell cycle progression and induces cytokinesis failure","volume":"26","author":"Carleton","year":"2006","journal-title":"Molecular and Cellular Biology"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"e61664","DOI":"10.1371\/journal.pone.0061664","article-title":"The motor protein KIF14 inhibits tumor growth and cancer metastasis in lung adenocarcinoma","volume":"8","author":"Hung","year":"2013","journal-title":"PLoS One"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"625199","DOI":"10.3389\/fonc.2020.625199","article-title":"Game of bones: How myeloma manipulates its microenvironment","volume":"10","author":"Moser-Katz","year":"2020","journal-title":"Frontiers in Oncology"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1074\/jbc.REV119.007759","article-title":"Cell adhesion in cancer: Beyond the migration of single cells","volume":"295","author":"Janiszewska","year":"2020","journal-title":"The Journal of Biological Chemistry"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"8975","DOI":"10.3390\/curroncol29110705","article-title":"Treating multiple myeloma in the context of the bone marrow microenvironment","volume":"29","author":"Ho","year":"2022","journal-title":"Current Oncology"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"3764","DOI":"10.3390\/cancers15153764","article-title":"Proteomic and metabolomic analysis of bone marrow and plasma from patients with extramedullary multiple myeloma identifies distinct protein and metabolite signatures","volume":"15","author":"Dunphy","year":"2023","journal-title":"Cancers"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0955-0674(98)80041-0","article-title":"Cell-adhesion-dependent influences on genomic instability and carcinogenesis","volume":"10","author":"Tlsty","year":"1998","journal-title":"Current Opinion in Cell Biology"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3390\/cancers13020215","article-title":"Treatment strategies considering micro-environment and clonal evolution in multiple myeloma","volume":"13","author":"Suzuki","year":"2021","journal-title":"Cancers"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0305-7372(03)00077-X","article-title":"The tumor microenvironment: Focus on myeloma","volume":"29","author":"Dalton","year":"2003","journal-title":"Cancer Treatment Reviews"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41408-023-00852-4","article-title":"Conditional survival in multiple myeloma and impact of prognostic factors over time","volume":"13","author":"Abdallah","year":"2023","journal-title":"Blood Cancer Journal"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s12935-020-01355-z","article-title":"Identification of key biomarkers associated with cell adhesion in multiple myeloma by integrated bioinformatics analysis","volume":"20","author":"Peng","year":"2020","journal-title":"Cancer Cell International"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.2517-6161.1996.tb02080.x","article-title":"Regression shrinkage and selection via the lasso","volume":"58","author":"Tibshirani","year":"1996","journal-title":"Journal of the Royal Statistical Society Series B: Statistical Methodology"}],"container-title":["Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.techscience.com\/files\/or\/2024\/TSP_OR-32-4\/OncolRes-32-04-43647\/OncolRes-32-43647.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T06:35:18Z","timestamp":1741242918000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.techscience.com\/or\/v32n4\/55760"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":57,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024]]},"published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.32604\/or.2023.043647","relation":{},"ISSN":["1555-3906"],"issn-type":[{"value":"1555-3906","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"2023-07-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-23","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-20","order":2,"name":"published","label":"Published Online","group":{"name":"publication_history","label":"Publication History"}}]}}